Welcome to the Leibniz-Institut für Molekulare Pharmakologie (FMP)

The FMP conducts basic research in Molecular Pharmacology with the aim to identify novel bioactive molecules and to characterize their interactions with their biological targets in cells or organisms. These compounds are useful tools in basic biomedical research and may be further developed for the treatment, prevention, or diagnosis of disease.
To this aim FMP researchers study key biological processes and corresponding diseases, such as cancer, aging including osteoporosis, or neurodegeneration. They also develop and apply advanced technologies ranging from screening technologies over NMR based methods to proteomics and in vivo models.

Research Highlights

Entry from: 04.02.2015  
Category: Research Highlights

Synchronization in the brain: a potassium channel harmonizes neuronal activity

NATURE COMMUNICATIONS Voltage-activated potassium channels dampen the excitability of neurons and act as set screws to fine-tune the inner workings of the brain. The role of a recently investigated channel subtype, potassium channel KCNQ5, was surprising: [more]

Entry from: 10.11.2014  
Category: Research Highlights

Protein Phosphorylation: Hunting the Phantom

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY Proteins are masters of metamorphosis: they are transformed, activated or deactivated in the cells as required. These vital modification processes have been the subject of research for many years, but some have only become (...)[more]

Entry from: 27.08.2014  
Category: Research Highlights

The search for the VRAC

SCIENCE The Jentsch lab and the FMP Screening Unit identify a long-sought channel that helps cells reduce their volume[more]

Entry from: 04.08.2014  
Category: Research Highlights

Brightly illuminated: Novel magnetic resonance diagnostics can detect diseased cells

PNAS Cell biologists, chemists and physicists from Berlin have successfully demonstrated the functionality of targeted xenon magnetic resonance imaging. The method could be used to specifically visualise pathological changes or certain cells of the body.[more]

Entry from: 04.06.2014  
Category: Research Highlights

Turbocharger for nerve cells: operation of ADHS gene investigated

CELL REPORTS AND NEURON Individuals with attention-deficit/hyperactivity syndrome (ADHS) often have a higher frequency of mutations in the gene for GIT1 – the research group headed by Volker Haucke has now established the role played by this protein at neuronal (...)[more]

 

Leibniz-Institut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10
13125 Berlin, Germany
+4930 94793 - 100 
+4930 94793 - 109 (Fax)
info(at)fmp-berlin.de